Results 251 to 260 of about 637,902 (343)

Multicentre surveillance study on feasibility, safety and efficacy of antifungal combination therapy for proven or probable invasive fungal diseases in haematological patients: the SEIFEM real‐life combo study

open access: yesMycoses (Berlin), 2013
A. Candoni   +16 more
semanticscholar   +1 more source

Distinct airway mycobiome signature in patients with pulmonary hypertension and subgroups. [PDF]

open access: yesBMC Med
Zhang C   +22 more
europepmc   +1 more source

Alternative Immunosuppression in Acquired Haemophilia A

open access: yes
Haemophilia, EarlyView.
Jayna Mistry   +3 more
wiley   +1 more source

Coccidioidomycosis Prophylaxis in Liver, Kidney, and Heart Transplant Recipients Residing in Endemic Areas Within the United States

open access: yesTransplant Infectious Disease, Volume 27, Issue 2, March/April 2025.
Our data suggests that abdominal organ transplant recipients residing in CM‐endemic areas with no prior CM exposure may not require CM prophylaxis. Therefore, we recommend implementing a shared decision‐making model among healthcare providers and patients for this lower‐risk patient population.
Faiza Morado   +5 more
wiley   +1 more source

Aspergillus After Lung Transplantation: Prophylaxis, Risk Factors, and the Impact on Chronic Lung Allograft Dysfunction

open access: yesTransplant Infectious Disease, EarlyView.
Out of 274 lung transplant (LTx) patients, 89 (32%) developed invasive aspergillosis IA. Factors associated with IA were mycophenolate mofetil use, airway stenosis, Aspergillus cultured pre‐LTx, chronic lung allograft dysfunction (CLAD), and acute rejection. The role of nebulized amphotericin B and statins for prevention of IA remains unclear. ABSTRACT
Johanna P. van Gemert   +7 more
wiley   +1 more source

The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation

open access: yesTransplant Infectious Disease, EarlyView.
Abstract Background Infections occurring in the early post–heart transplant (HT) period heavily contribute to morbidity and mortality. Our goal is to evaluate the incidence of hospital‐acquired pneumonia/ventilator‐associated pneumonia (HAP/VAPs) and/or bloodstream infections (BSIs) after HT during the intensive care unit (ICU) stay and identify their ...
Rita Minucci   +10 more
wiley   +1 more source

Point‐of‐Care Testing by Multiplex‐PCR in Different Compartments in Suspected Lower Respiratory Tract Infection After Lung Transplantation—Results of a Prospective Study

open access: yesTransplant Infectious Disease, EarlyView.
Use of POCtmPCR with noninvasive samples (NPS and sputum) in LTx recipients with viral LRTI are a viable alternative to invasive BAL sampling, ABSTRACT Background Respiratory tract infections (RTIs) are a leading cause of morbidity and mortality following lung transplantation (LTx).
Susanne Simon   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy